By the highly credentialed Dr. Burton Berkson:
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases.
Berkson BM, Rubin DM, Berkson AJ.
Integr Cancer Ther. 2009 Dec;8(4):416-22. doi: 10.1177/1534735409352082. Erratum in: Integr Cancer Ther. 2010 Jun;9(2):247.
Related citations
Reversal of signs and symptoms of a B-cell lymphoma in a patient using only low-dose naltrexone.
Integr Cancer Ther. 2007 Sep;6(3):293-6. No abstract available.
The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol.
Integr Cancer Ther. 2006 Mar;5(1):83-9.
Donate to CureZone
CureZone Newsletter is distributed in partnership with https://www.netatlantic.com
Contact Us - Advertise - Stats
0.219 sec, (6)